GLP-1 Drugs Could Nudge Some Men Toward Hair Loss, Study Suggests
Further investigation needed.
“`html
A new investigation from researchers at New York University has identified a potential link between popular weight-loss medications and male-pattern hair loss. The study, published in the Journal of Investigative Dermatology, examined whether GLP-1 drugs like Ozempic and Wegovy could increase hair loss risk in genetically susceptible men. While patients have previously reported hair thinning as a side effect, this research represents the first scientific evidence establishing a connection between these medications and androgenetic alopecia.
Rather than observing actual patients taking the drugs, the research team employed a genetic analysis method called Mendelian Randomization. Scientists identified 22 genetic variants associated with increased GLP-1 receptor activity and cross-referenced them against a database of over 205,000 individuals. Men with pattern hair loss showed a 7 percent higher likelihood of carrying these genetic variants, suggesting that elevated GLP-1 receptor levels may contribute to hair loss. The researchers adjusted for other variables including blood pressure, testosterone levels, and body fat distribution to ensure accuracy.
Though the findings suggest a meaningful association, experts emphasize that the effect size remains modest and clinical significance is still uncertain. Scientists believe GLP-1 drugs may either directly affect hair follicles or indirectly influence hair growth through metabolic pathways. Researchers propose that future screening could identify at-risk men before treatment begins, potentially allowing doctors to prescribe preventive therapies like minoxidil alongside GLP-1 medications to mitigate hair loss concerns.
“`
Originally reported by Sciencealert →
About the Author
